39354-6

Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase

Active

Part Descriptions

LP14299-9   Cholinesterase
In biochemistry, cholinesterase is a family of enzymes that catalyze the hydrolysis of the neurotransmitter acetylcholine into choline and acetic acid, a reaction necessary to allow a cholinergic neuron to return to its resting state after activation.

There are two types:
1. Acetylcholinesterase (EC 3.1.1.7) (AChE), also known as RBC cholinesterase, erythrocyte cholinesterase, or (most formally) acetylcholine acetylhydrolase, found primarily in the blood and neural synapses. Acetylcholinesterase exists in multiple molecular forms. In the mammalian brain the majority of AChE occurs as a tetrameric, G4 form (10) with much smaller amounts of a monomeric G1 (4S) form.
2. Pseudocholinesterase (EC 3.1.1.8) (BChE or BuChE), also known as plasma cholinesterase, butyrylcholinesterase, or (most formally) acylcholine acylhydrolase, found primarily in the liver.

The difference between the two types of cholinesterase has to do with their respective preferences for substrates: the former hydrolyses acetylcholine more quickly; the latter hydrolyses butyrylcholine more quickly.

The half-life of pseudocholinesterase is approximately 8-16 hours. Pseudocholinesterase levels may be reduced in patients with advanced liver disease. The decrease must be greater than 75% before significant prolongation of neuromuscular blockade occurs with succinylcholine.

An absence or mutation of the pseudocholinesterase enzyme leads to a medical condition known as pseudocholinesterase deficiency. This is a silent condition that manifests itself only when people that have the deficiency receive the muscle relaxants succinylcholine or mivacurium during a surgery.
Pseudocholinesterase deficiency may also affect local anaesthetic selection in dental procedures. The enzyme plays an important role in the metabolism of ester-based local anaesthetics, a deficiency lowers the margin of safety and increases the risk of systemic effects with this type of anaesthetic. The selection of an amide-based solution is recommended in such patients.
Elevation of plasma pseudocholinesterase was observed in 90.5% cases of acute myocardial infarction.
The presence of acetylcholinesterase in the amniotic fluid may be tested in early pregnancy. A sample of amniotic fluid is removed by amniocentesis, and presence of AChE can confirm several common types of birth defect, including abdominal wall defects and neural tube defects.
Butyrylcholinesterase can be used as a prophylactic agent against nerve gas and other organophosphate poisoning Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Cholinesterase (Wikipedia)

LP14299-9   Cholinesterase
Cholinesterase is measured to diagnose organophosphate and carbamate toxicity or identify atypical enzyme forms. RBC levels measured to detect chronic exposure to systemic insecticides. Insecticides inhibit both RBC and plasma cholinesterase levels, but serum levels return to normal before RBC levels normalize. Cholinesterase is irreversibly inhibited by organophosphate insecticides and reversibly inhibited by carbamate insecticides. Information from LOINC partner 1 2006 10 24.

Pseudocholinesterase is also known as plasma cholinesterase, butyrylcholinesterase, or (most formally) acyl choline acylhydrolase, found primarily in the liver. An absence or mutation of the pseudocholinesterase enzyme leads to a medical condition known as pseudocholinesterase deficiency, which is a silent condition which only manifests itself when people who have the deficiency receive the muscle relaxants succinylcholine or mivacurium during surgery. Information from en.Wikipedia.org. Source: Regenstrief Institute

Fully-Specified Name

Component

Cholinesterase^dibucaine/Cholinesterase

Property

CFr

Time

Pt

System

Ser/Plas

Scale

Qn

Method

Additional Names

Short Name

Cholinesterase dibucaine/CHe CFr SerPl

Display Name

Cholinesterase dibucaine/Cholinesterase [Catalytic fraction]

Consumer Name Alpha Get Info

Cholinesterase dibucaine/Cholinesterase, Blood

Basic Attributes

Class

CHEM

Type

Laboratory

First Released

Version 2.15

Last Updated

Version 2.73

Change Reason

Changed component from Cholinesterase.dibucaine inhibited to fit the current LOINC model for challenges

Order vs. Observation

Observation

Common Test Rank Get Info

9001

Member of these Panels

Language Variants Get Info

Related Names

• Acylcholine acylhydrolase
• BChE
• Benzoyl cholinesterase
• Benzoylcholinesterase
• Butyrylcholine esterase
• Catalytic Fraction
• Che
• Chemistry
• Chincocaine
• Choline esterase II
• CHS
• dibucaine/CHe
• Nupercainal
• Percent
• Pl
• Plasma
• Plsm
• Point in time
• Pseudocho
• Pseudocholinesterase
• QNT
• Quan
• Quant
• Quantitative
• Random
• SerP
• SerPl
• SerPlas
• Serum
• Serum or plasma
• SR

Example Units

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=39354-6

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.